Item Type | Name |
Concept
|
Central Nervous System Stimulants
|
Concept
|
Central Nervous System Depressants
|
Concept
|
Endocrine System Diseases
|
Concept
|
Endocrine System
|
Concept
|
Fatty Acids, Nonesterified
|
Concept
|
Glial Fibrillary Acidic Protein
|
Concept
|
Hypothalamo-Hypophyseal System
|
Concept
|
Immune System
|
Concept
|
Limbic System
|
Concept
|
Monosaccharide Transport Proteins
|
Concept
|
Nervous System Diseases
|
Concept
|
Pituitary-Adrenal System
|
Concept
|
Pyrrolidonecarboxylic Acid
|
Concept
|
Receptors, Amino Acid
|
Concept
|
Excitatory Amino Acid Agonists
|
Concept
|
Excitatory Amino Acid Antagonists
|
Concept
|
Glutamic Acid
|
Concept
|
Amino Acid Transport System X-AG
|
Concept
|
Fatty Acid-Binding Proteins
|
Academic Article
|
Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
|
Academic Article
|
The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine.
|
Academic Article
|
The role of endogenous dynorphin in ethanol-induced state-dependent CPP.
|
Academic Article
|
The endocrine effects of nicotine and cigarette smoke.
|
Academic Article
|
Specific reduction of G6PT may contribute to downregulation of hepatic 11?-HSD1 in diabetic mice.
|
Academic Article
|
Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice.
|
Academic Article
|
The effects of opioids and opioid analogs on animal and human endocrine systems.
|
Academic Article
|
11?-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
|
Academic Article
|
Molecular Changes in Opioid Addiction: The Role of Adenylyl Cyclase and cAMP/PKA System.
|
Academic Article
|
Novel role of the nociceptin system as a regulator of glutamate transporter expression in developing astrocytes.
|
Academic Article
|
A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in Mice.
|
Academic Article
|
A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers.
|
Academic Article
|
Emerging evidence for the role of pituitary adenylate cyclase-activating peptide in neuropsychiatric disorders.
|
Academic Article
|
Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice.
|
Academic Article
|
Sensitization to cocaine after a single intra-cerebral injection of orphanin FQ/nociceptin.
|
Academic Article
|
Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice.
|
Academic Article
|
Cellular colocalization and coregulation between hypothalamic pro-TRH and prohormone convertases in hypothyroidism.
|
Academic Article
|
Repeated stress alters the ability of nicotine to activate the hypothalamic-pituitary-adrenal axis.
|
Academic Article
|
The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference.
|
Academic Article
|
Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulation.
|
Academic Article
|
Potentiation of opioid analgesia by cocaine: the role of spinal and supraspinal receptors.
|
Academic Article
|
Species differences in mu- and delta-opioid receptors.
|
Academic Article
|
Dissociation of opioid receptor upregulation and functional supersensitivity.
|
Academic Article
|
The role of opioid receptor density in morphine tolerance.
|
Academic Article
|
In vitro d-amphetamine and cocaine increase opioid binding in mouse brain homogenate.
|
Academic Article
|
Tolerance develops to spinal morphine analgesia but not morphine-induced convulsions.
|
Academic Article
|
Modification of morphine-induced analgesia and toxicity by pertussis toxin.
|
Academic Article
|
Differentiation of spinal and supraspinal opioid receptors by morphine tolerance.
|
Academic Article
|
Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
|
Academic Article
|
Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia.
|
Academic Article
|
Chronic opioid antagonist treatment: assessment of receptor upregulation.
|
Academic Article
|
ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice.
|
Academic Article
|
Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
|
Academic Article
|
Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice.
|
Academic Article
|
Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats.
|
Academic Article
|
Antinociceptive effects of NMDA and non-NMDA receptor antagonists in the tail flick test in mice.
|
Academic Article
|
Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice.
|
Academic Article
|
ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
|
Academic Article
|
ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
|
Academic Article
|
Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
|
Academic Article
|
Gene expression profiling following short-term and long-term morphine exposure in mice uncovers genes involved in food intake.
|
Academic Article
|
Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.
|
Academic Article
|
Increased glycogen synthase kinase-3? and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.
|
Academic Article
|
Decreased 11?-Hydroxysteroid Dehydrogenase Type 2 Expression in the Kidney May Contribute to Nicotine/Smoking-Induced Blood Pressure Elevation in Mice.
|
Academic Article
|
The Influence of Cross-Fostering on Alcohol Consumption and Depressive-Like Behaviors in HA and LA Mice: The Role of the Endogenous Opioid System.
|
Academic Article
|
Identification of 5-Hydroxycotinine in the Plasma of Nicotine-Treated Mice: Implications for Cotinine Metabolism and Disposition in Vivo.
|
Academic Article
|
The PACAP/PAC1 Receptor System and Feeding.
|
Academic Article
|
Glial Glutamate Transporter Modulation Prevents Development of Complete Freund's Adjuvant-Induced Hyperalgesia and Allodynia in Mice.
|
Academic Article
|
Chronic Exposure to E-Cigarettes Elevates CYP2A5 Activity, Protein Expression, and Cotinine-Induced Production of Reactive Oxygen Species in Mice.
|
Academic Article
|
The role of Neurochemicals, Stress Hormones and Immune System in the Positive Feedback Loops between Diabetes, Obesity and Depression.
|